Reliance Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 29 Mar 2017 66.45 -0.32
(-0.48%)

NAV High-Low (in Rs)

ONE Mth
52-WEEk 1456.09
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 0.49 - - 5.4 16.69
Sensex 1.07 3.15 6.39 17.01 32.71
Nifty 0.96 3.31 6.53 18.6 37.01

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 6.50 (Rs) 27-02-2017
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 28 Feb 2017
Category Share (%)
CBLO 0.59
Equity 97.66
Net CA & Others 1.75
› More
   As On 28 Feb 2017
Sector Name Amount
Finance & Investments 4.09
Healthcare 4.54
Miscellaneous 6.11
NA 2.34
Pharmaceuticals - Indian - Bulk Drugs 14.88
Pharmaceuticals - Indian - Bulk Drugs & Formln 51.41
Pharmaceuticals - Multinational 16.63
› More
   As On 28 Feb 2017
Company Name
Cadila Health. 9.77
Aurobindo Pharma 9.34
Abbott India 9.02
Sun Pharma.Inds. 8.68
Divi's Lab. 7.94
Sanofi India 7.61
Lupin 6.94
Dr Reddy's Labs 6.82
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Capital Asset Management Company,

One Indiabulls Centre Tower 1
12th Flr 841 Senapati Bapat
Marg Elphinstone Road Mumbai-400013

Phone: 022-30994600 | Fax: 022-30994699

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com